Jinneng Science&Techology Co.,Ltd (603113.SS) Bundle
Who is buying Jinneng Science&Technology Co., Ltd. (603113.SS) - and why? With a market capitalization of CNY 5.22 billion, a trailing P/E of 150.02 and a forward P/E of 46.13, investors are weighing valuation against growth as the company posts a TTM revenue of CNY 16.81 billion (up 6.25% YoY); in H1 2025 Jinneng reported net income of CNY 26.43 million with EPS of CNY 0.03 and declared a cash dividend of CNY 2.35 per 10 shares, while its diversified chemical portfolio - carbon black, coke, para cresol, sorbic acid, potassium sorbate, silica, methanol and pure benzene - plus exports to Europe, North America and Asia and integrated production capabilities explain interest from both domestic state-backed holders (Jinneng Holding Group as the largest shareholder) and institutional investors (holding ~18.26%) alongside insiders controlling ~40.23% of shares; the firm's registered capital of CNY 847,945,324 with 847.95 million shares outstanding, a 2022 capital expenditure of ~CNY 6 billion, a debt-to-equity ratio of 0.83 and positive operating cash flow of CNY 216.55 million are all driving distinct investor bets amid pricing pressure and regulatory headwinds - read on to see which investor types are positioning for stability, growth or yield.
Jinneng Science&Techology Co.,Ltd (603113.SS) Who Invests in Jinneng Science&Techology Co.,Ltd (603113.SS) and Why?
Jinneng Science&Techology Co.,Ltd (603113.SS) draws a mixed investor base attracted by revenue growth, diversified product exposure in chemicals, cash-return policies and international sales. Below are the primary investor profiles and the reasons they allocate capital to Jinneng.- Domestic institutional investors - mutual funds and asset managers seeking exposure to China's specialty chemicals sector while balancing cyclical risk with stable cash-generative product lines.
- Retail investors - drawn by dividend yield signals and recovery narratives after recent net losses; the declared H1 2025 cash dividend (CNY 2.35 per 10 shares) is a strong retail magnet.
- Value-oriented investors - targeting companies with infrastructure, integrated production and potential margin recovery when commodity cycles turn.
- Growth/turnaround investors - attracted by positive revenue momentum (TTM revenue up 6.25% YoY) and forward P/E that implies expectations of earnings normalization (forward P/E 46.13).
- Export-focused and global funds - attracted by Jinneng's international sales footprint across Europe, North America and Asia, providing geographic diversification.
- Strategic/industrial partners - companies in downstream industries (tires, coatings, preservatives, solvents) interested in secure supply of carbon black, para cresol, sorbic acid and related products.
| Metric | Value |
|---|---|
| Market capitalization (as of 2025-12-12) | CNY 5.22 billion |
| Trailing P/E | 150.02 |
| Forward P/E | 46.13 |
| Revenue (TTM) | CNY 16.81 billion (6.25% YoY) |
| Net income (H1 2025) | CNY 26.43 million |
| EPS (H1 2025) | CNY 0.03 |
| Dividend declared (H1 2025) | CNY 2.35 per 10 shares |
- Product diversification - carbon black, coke, para cresol, sorbic acid, potassium sorbate, silica, methanol, pure benzene - reduces single-product dependency and attracts investors wanting broad chemical exposure.
- Integrated production advantage - vertical integration yields cost advantages and margin resilience that appeal to long-term, industrially focused investors.
- Export & market diversification - presence in Europe, North America and Asia mitigates single-market risk and draws cross-border investors.
- Dividend policy - tangible shareholder returns (cash dividend) support investor confidence despite recent net losses.
Institutional Ownership and Major Shareholders of Jinneng Science&Techology Co.,Ltd (603113.SS)
Jinneng Science&Techology Co.,Ltd shows a mixed ownership structure with significant insider control, a meaningful state-owned strategic stake, and moderate institutional participation as of 11 July 2025.- Institutional investors: ~18.26% of total shares, reflecting moderate institutional interest and room for increased institutional accumulation.
- Insider ownership: ~40.23%, indicating substantial confidence and control by management and key stakeholders.
- Largest shareholder: Jinneng Holding Group (state-owned enterprise), holding a substantial strategic stake that underscores the company's importance in regional/sector planning.
| Metric | Value |
|---|---|
| Registered capital | CNY 847,945,324 |
| Total shares outstanding | 847.95 million shares |
| Institutional ownership (as of 2025-07-11) | 18.26% |
| Insider ownership | 40.23% |
| Largest shareholder | Jinneng Holding Group (state-owned) |
| Capital expenditure (2022) | ≈ CNY 6,000,000,000 |
| Debt-to-equity ratio | 0.83 |
- Implication for investors: high insider stake can align management and shareholder interests but may limit free float; institutional stake near 18% suggests selective professional interest.
- Balance sheet/strategy signal: CNY 6bn capex in 2022 and a 0.83 debt/equity ratio point to active capacity buildout funded through a mix of debt and equity - moderate leverage.
Jinneng Science&Techology Co.,Ltd (603113.SS) Key Investors and Their Impact on Jinneng Science&Techology Co.,Ltd
Jinneng Science&Techology's shareholder mix and recent capital allocation signal how different investor groups shape strategy, governance and operational priorities.- Largest shareholder: Jinneng Holding Group - provides strategic direction, access to industry resources and long-term stability.
- Insiders (40.23%): strong management/insider alignment with shareholder interests, likely supporting performance-driven decisions and continuity.
- Institutional investors (18.26%): bring governance oversight, analytical scrutiny and potential activist or engagement influence on capital allocation.
| Investor Group | Ownership (%) | Primary Influence |
|---|---|---|
| Jinneng Holding Group | - Largest shareholder (exact stake held by group entities varies) | Strategic direction, resource backing, industry relationships |
| Insiders (Mgmt & Board) | 40.23% | Alignment of executive incentives with shareholders; operational continuity |
| Institutional Investors | 18.26% | Governance pressure, capital-markets discipline, engagement on strategy |
| Other Shareholders | Remaining (~41.51%) | Retail and other corporate holders providing liquidity and market pricing |
- Capital expenditure in 2022: CNY 6.00 billion - funded via a mix of debt and equity, signaling commitment to expansion and investor backing for growth initiatives.
- Debt-to-equity ratio: 0.83 - reflects a balanced leverage approach aimed at optimizing cost of capital while retaining financial flexibility.
- Operating cash flow: CNY 216.55 million - positive OCF indicates operational cash generation supporting debt service and capex.
Jinneng Science&Techology Co.,Ltd (603113.SS) - Market Impact and Investor Sentiment
Jinneng Science&Techology Co.,Ltd (603113.SS) presents a mixed but net-positive narrative for investors: a market capitalization of CNY 5.22 billion and a trailing P/E of 150.02 signal strong investor optimism despite recent net losses, while revenue growth of 6.25% year-over-year and a shareholder cash dividend underline operational resilience and shareholder-aligned capital allocation.
- Market capitalization: CNY 5.22 billion - implies mid-cap positioning within the chemical/materials sector and liquidity profile attractive to domestic institutional investors.
- Trailing P/E: 150.02 - elevated multiple reflecting growth expectations, scarce earnings base (recent net losses) or investor willingness to pay a premium for future scalability.
- Revenue growth (YoY): 6.25% - steady top-line momentum supporting sentiment despite margin pressure.
- Cash dividend: CNY 2.35 per 10 shares - explicit return-of-capital policy that reassures income-seeking shareholders and signals board confidence in cash generation.
Key strategic and market factors shaping sentiment include product diversification, international sales channels, capital allocation choices, and operational scale that help offset sector headwinds such as pricing pressure and tightening environmental regulation. For additional corporate background and structural context, see Jinneng Science&Techology Co.,Ltd: History, Ownership, Mission, How It Works & Makes Money.
| Metric | Value | Investor Implication |
|---|---|---|
| Market Capitalization | CNY 5.22 billion | Mid-cap liquidity; accessible to domestic institutional flows |
| Trailing P/E | 150.02 | High growth premium or low earnings base |
| Revenue Growth (YoY) | 6.25% | Positive top-line trajectory |
| Cash Dividend | CNY 2.35 per 10 shares | Support for income-focused investors; signal of cash confidence |
| Capital Expenditure | Substantial (company-reported) | Indicates reinvestment into capacity and modernization |
| Debt-to-Equity | Not disclosed (reported as balanced) | Described by company as balanced financial leverage |
| Key Risks | Pricing pressure, environmental regulations | Potential margin compression and compliance costs |
| Competitive Advantages | Diversified product portfolio, established infrastructure, technical expertise | Supports resilience and investor confidence |
- Primary investor cohorts: domestic institutional funds (drawn by yield via dividends and growth outlook), growth-oriented retail investors (attracted by high P/E and revenue growth), and strategic long-term holders valuing industrial capability.
- Sentiment drivers to monitor: quarterly earnings vs. expectations, capex execution and ROI, regulatory updates, and margin trends under pricing pressure.

Jinneng Science&Techology Co.,Ltd (603113.SS) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.